UHealth - University of Miami Health System

Yu Zhang

General Information

Yu  Zhang

Contact

  • .(JavaScript must be enabled to view this email address)

Languages

  • English

Roles

  • Research Asst. Professor

CV

Research Interests

 

Study the role of B cell in regulation of anti-tumor response in solid tumor. Identify a subset of the B regulatory cells in the solid tumor and their phenotype and function in suppressing T cell anti-tumor response. In mouse model, B cells upon migration into tumor microenvironment and in contact with tumor cells become suppressor cells like T regulatory cells, we named that subset of B cells as B regulatory cells (Breg cells). This type of B cells over-express inhibitory co-stimulatory molecules, such as CD86, PD-L1, B7-H2, and membrane-bound TGF-b. These Bregs suppressed CD4 and CD8 T cell activation, proliferation and Th1 cytokine secretion in vitro and in vivo. Similar Breg activity may be identified in human solid tumors as well as lymphoid malignancies. Whether Breg populations could be targeted in an effort to enhance anti-tumor T cell responses requires better definition of the immune suppressive Breg population in man.

Awards

Post-Doctoral Fellowships
Sidney Kimmel Cancer Center

Education

1984-1989 Medicine
HeNan University to Traditional Chinese Medicine (Formally Chinese Medical University),

Publications

  • Ahmed Al Bayati, Yu Zhang, Joseph D Rosenblatt, B Cell Regulation of Anti-Tumor Response, chapter 15. Springer New York Heidelberg Dordrecht London, 2014, in press.
  • Zhang, Y, Schreiber, T.H., and Rosenblatt, J.D. The Role of B cells in Shaping the Antitumor Immune Response, 19-35, 2013. Advances in Tumor Immunology and Immunotherapy, Springer New York Heidelberg Dordrecht London, 2013: ISBN 978-1-4614-8808-8. Editors: Joseph D. Rosenblatt, Eckhard R. Podack, Glen N. Barber, Augusto Ochoa
  • Zhang,Y Hovav Nechustac Andrew Chan, Eckhard Podack, Robert Levy, and Joseph D. Rosenblatt, Immune effects of B cell depletion on the T cell response: Analysis in the human CD20 transgenic mouse model, 33-49, 2007. Rituximab-mediated Molecular Signaling and Interaction with Chemotherapeutic Drugs, Transworld Research Network, 2007: ISBN: 81-7895-256-4. Editor: Benjamin Bonavida